A network of protein interactions determines polyglutamine toxicity
- PMID: 16832049
- PMCID: PMC1544172
- DOI: 10.1073/pnas.0604548103
A network of protein interactions determines polyglutamine toxicity
Abstract
Several neurodegenerative diseases are associated with the toxicity of misfolded proteins. This toxicity must arise from a combination of the amino acid sequences of the misfolded proteins and their interactions with other factors in their environment. A particularly compelling example of how profoundly these intramolecular and intermolecular factors can modulate the toxicity of a misfolded protein is provided by the polyglutamine (polyQ) diseases. All of these disorders are caused by glutamine expansions in proteins that are broadly expressed, yet the nature of the proteins that harbor the glutamine expansions and the particular pathologies they produce are very different. We find, using a yeast model, that amino acid sequences that modulate polyQ toxicity in cis can also do so in trans. Furthermore, the prion conformation of the yeast protein Rnq1 and the level of expression of a suite of other glutamine-rich proteins profoundly affect polyQ toxicity. They can convert polyQ expansion proteins from toxic to benign and vice versa. Our work presents a paradigm for how a complex, dynamic interplay between intramolecular features of polyQ proteins and intermolecular factors in the cellular environment might determine the unique pathobiologies of polyQ expansion proteins.
Conflict of interest statement
Conflict of interest statement: No conflicts declared.
Figures
Similar articles
-
Flanking sequences profoundly alter polyglutamine toxicity in yeast.Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11045-50. doi: 10.1073/pnas.0604547103. Epub 2006 Jul 10. Proc Natl Acad Sci U S A. 2006. PMID: 16832050 Free PMC article.
-
Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.J Cell Biol. 2002 Jun 10;157(6):997-1004. doi: 10.1083/jcb.200112104. Epub 2002 Jun 10. J Cell Biol. 2002. PMID: 12058016 Free PMC article.
-
Formation of toxic oligomers of polyQ-expanded Huntingtin by prion-mediated cross-seeding.Mol Cell. 2022 Nov 17;82(22):4290-4306.e11. doi: 10.1016/j.molcel.2022.09.031. Epub 2022 Oct 21. Mol Cell. 2022. PMID: 36272412
-
Cellular factors important for the de novo formation of yeast prions.Biochem Soc Trans. 2008 Oct;36(Pt 5):1083-7. doi: 10.1042/BST0361083. Biochem Soc Trans. 2008. PMID: 18793193 Review.
-
Defining the limits: Protein aggregation and toxicity in vivo.Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):294-303. doi: 10.3109/10409238.2014.914151. Epub 2014 Apr 28. Crit Rev Biochem Mol Biol. 2014. PMID: 24766537 Free PMC article. Review.
Cited by
-
Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast.PLoS Genet. 2012;8(4):e1002634. doi: 10.1371/journal.pgen.1002634. Epub 2012 Apr 19. PLoS Genet. 2012. PMID: 22536159 Free PMC article.
-
RNA-binding proteins with prion-like domains in ALS and FTLD-U.Prion. 2011 Jul-Sep;5(3):179-87. doi: 10.4161/pri.5.3.17230. Epub 2011 Jul 1. Prion. 2011. PMID: 21847013 Free PMC article. Review.
-
Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy.Protein Cell. 2011 Feb;2(2):141-9. doi: 10.1007/s13238-011-1014-5. Epub 2011 Feb 14. Protein Cell. 2011. PMID: 21327870 Free PMC article.
-
Aggregation of polyQ proteins is increased upon yeast aging and affected by Sir2 and Hsf1: novel quantitative biochemical and microscopic assays.PLoS One. 2012;7(9):e44785. doi: 10.1371/journal.pone.0044785. Epub 2012 Sep 6. PLoS One. 2012. PMID: 22970306 Free PMC article.
-
A network of genes connects polyglutamine toxicity to ploidy control in yeast.Nat Commun. 2013;4:1571. doi: 10.1038/ncomms2575. Nat Commun. 2013. PMID: 23481379 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
